Get 40% Off
💰 Ray Dalio just increased his holdings in Google by 162.61% - See the full portfolio with InvestingPro’s free Stock Ideas toolCopy Portfolios

Ashland (ASH) To Raise BDO And Derivatives Prices In EMEA

Published 03/25/2018, 09:35 PM
Updated 07/09/2023, 06:31 AM
ASH
-
KRO
-
LYB
-
BASFY
-

Ashland Global Holdings Inc. (NYSE:ASH) will increase prices of 1-4 butanediol and derivatives in Europe, the Middle East and Africa (EMEA). The price hike will be effective immediately or as contracts permit.

The company will increase the prices of 1-4 butanediol (BDO) by €100/MT and for derivatives (including THF, NMP, BLO, 2-Pyrol) up to €200/MT.

Ashland noted that the price increase reflects evolving market conditions and will help it to continue to serve its customers with the premium level services. The latest move follows a series of price increases announced by the company in the recent past.

Ashland is also taking appropriate pricing actions in response to raw material cost inflation. The company, earlier this month, announced price increase on epoxy vinyl ester and specialty resins in North America, effective from Apr 1, 2018. The move is driven by sustained rise in the costs of major raw materials.

Shares of Ashland have declined 44.6% over a year, significantly underperforming the industry’s 8.7% gain.


Ashland’s earnings and sales missed estimates in first-quarter fiscal 2018 (ended Dec 31, 2017). In the quarter, the company’s adjusted earnings came in at 46 cents per share, trailing the Zacks Consensus Estimate of 47 cents.

Revenues increased roughly 19.6% year over year to $842 million in the quarter. The figure, however, lagged the Zacks Consensus Estimate of $860 million.

For fiscal 2018, Ashland updated its adjusted earnings outlook to a range of $2.90-$3.10 per share owing to changes in the company’s effective tax rate. Also, the company raised effective tax rate expectation for the fiscal as a result of the recently enacted tax reform. This, in turn, is expected to reduce fiscal 2018 adjusted earnings by roughly 30 cents per share.

For second-quarter fiscal 2018, Ashland projects adjusted earnings in the range of 80-90 cents per share compared with 70 cents in the prior-year period. The company expects the benefit of pricing actions to be partly offset in the quarter by the impact of the planned maintenance shutdown in the Marl, Germany, facility.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Ashland Global Holdings Inc. Price and Consensus

Zacks Rank & Stocks to Consider

Ashland currently carries a Zacks Rank #5 (Strong Sell).

Some better-ranked stocks in the basic materials space are LyondellBasell Industries N.V. (NYSE:LYB) , Kronos Worldwide Inc. (NYSE:KRO) and BASF SE (OTC:BASFY) .

LyondellBasell has an expected long-term earnings growth rate of 9% and sports a Zacks Rank #1 (Strong Buy). The company’s shares have moved up 18% in a year. You can see the complete list of today’s Zacks #1 Rank stocks here.

Kronos has an expected long-term earnings growth rate of 5% and flaunts a Zacks Rank #1. Its shares have gained 43.5% over a year.

BASF has an expected long-term earnings growth rate of 6.7% and carries a Zacks Rank #2 (Buy). Its shares have moved up 1.3% in a year.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>



BASF SE (BASFY): Free Stock Analysis Report

Ashland Global Holdings Inc. (ASH): Free Stock Analysis Report

Kronos Worldwide Inc (KRO): Free Stock Analysis Report

LyondellBasell Industries N.V. (LYB): Free Stock Analysis Report

Original post
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.